Can bupropion increase ammonia levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bupropion is not known to directly increase ammonia levels in the body. This antidepressant medication, also known by brand names like Wellbutrin, works primarily by inhibiting the reuptake of dopamine and norepinephrine in the brain and does not typically affect liver function or nitrogen metabolism in ways that would elevate ammonia. Unlike some medications that can cause hepatotoxicity and subsequently lead to hyperammonemia, bupropion is generally not associated with this effect when used at prescribed doses. However, in patients with pre-existing liver disease or hepatic impairment, any medication including bupropion should be used with caution as the liver's reduced capacity to metabolize drugs could potentially exacerbate ammonia clearance issues. If a patient on bupropion experiences symptoms like confusion, lethargy, or altered mental status that might suggest elevated ammonia levels, they should seek medical attention promptly. These symptoms would more likely be related to other causes or conditions rather than a direct effect of bupropion on ammonia metabolism.

The provided evidence does not directly address the relationship between bupropion and ammonia levels, but it discusses various aspects of hyperammonemia, its management, and the role of different medications in pediatric patients. None of the studies mentioned (1) specifically investigate the effect of bupropion on ammonia levels. Therefore, the recommendation is based on the general understanding of bupropion's mechanism of action and its potential impact on liver function and nitrogen metabolism.

Key points to consider:

  • Bupropion's primary mechanism of action does not involve direct effects on ammonia metabolism.
  • Patients with pre-existing liver disease or hepatic impairment should use bupropion with caution.
  • Symptoms suggesting elevated ammonia levels should prompt medical attention, but are unlikely to be directly caused by bupropion.
  • The evidence provided does not support a direct link between bupropion and increased ammonia levels.

From the Research

Bupropion and Ammonia Levels

  • There is no direct evidence in the provided studies to suggest that bupropion increases ammonia levels 2, 3, 4, 5, 6.
  • The studies focus on the use of bupropion in treating depression, attention-deficit/hyperactivity disorder, and other conditions, as well as its pharmacology and therapeutic applications 2, 5, 6.
  • Hyperammonemia is discussed in the context of liver disease and septic shock, but not in relation to bupropion use 3, 4.
  • The mechanisms of action of bupropion, including its effects on dopamine and norepinephrine reuptake transporters, are described, but no mention is made of its impact on ammonia levels 5, 6.

Hyperammonemia

  • Hyperammonemia can lead to serious health consequences, including cerebral edema, encephalopathy, seizures, coma, and death 3.
  • Noncirrhotic hyperammonemia can occur due to increased production and/or decreased elimination of ammonia, and can be caused by various factors, including septic shock and urea cycle enzyme deficiencies 3.
  • Treatment of hyperammonemia may involve reducing the catabolic state, nitrogen scavenging, replacing urea cycle substrates, decreasing intestinal absorption, and augmented removal of ammonia with renal replacement therapy 3, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Nonhepatic Hyperammonemia With Septic Shock: Case and Review of Literature.

Journal of investigative medicine high impact case reports, 2022

Research

Ammonia clearance with haemofiltration in adults with liver disease.

Liver international : official journal of the International Association for the Study of the Liver, 2014

Research

Bupropion: pharmacology and therapeutic applications.

Expert review of neurotherapeutics, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.